How Do Wounds Heal? The Science of Tissue Repair

A cut on your finger seems trivial, yet within seconds your body initiates one of its most complex repair operations: a four-phase cascade involving platelets, immune cells, fibroblasts, and blood vessels that will take weeks to months to complete. The entire process is a masterpiece of molecular choreography. Hemostasis stops the bleeding; inflammation clears debris and recruits repair cells; proliferation builds new tissue; remodeling sculpts the final scar. Each phase depends on precise signaling, and disruption at any stage can lead to chronic, non-healing wounds affecting over 150 million people globally. Understanding wound healing is central to medicine because the same mechanisms that repair a small cut also drive recovery from surgery, burns, and trauma.

The First Response: Hemostasis and Blood Clotting

The instant skin is broken, exposed blood vessels trigger hemostasis — the process of stopping blood flow and forming a plug to seal the wound.

Platelets — small, disc-shaped cell fragments circulating in blood, are the first responders. When blood vessels are damaged, the endothelial cell layer ruptures and collagen in the vessel wall becomes exposed. Platelets detect this exposed collagen and other damage-associated molecules and adhere to the wound site within seconds. Adhering platelets change shape, becoming spiky and aggregating together in a process called platelet aggregation. They stick to each other, forming a loose platelet plug that physically blocks the opening.

This plug, however, is not a permanent seal. It relies on weak adhesion forces and will wash away with blood flow. The body must reinforce it with a fibrous mesh called a clot or thrombus.

Coagulation — the formation of fibrin strands — begins when damaged blood vessels release tissue factor into the bloodstream. Tissue factor initiates a cascade of protein activations, a "waterfall" of enzymes called the coagulation cascade. Each enzyme in the cascade activates the next, amplifying the signal. The cascade culminates in the activation of thrombin, a protease that cleaves fibrinogen — a large plasma protein — into fibrin monomers. These monomers polymerize into long, insoluble threads that form a fibrous mesh entrapping platelets, blood cells, and wound margins. This mesh is the clot.

Thrombin simultaneously activates platelets further, increasing their aggregation, and triggers the activation of platelets' dense granules, releasing stored ADP and serotonin, which amplify platelet recruitment. The result is a stable, multi-layered plug: an outer layer of tightly packed platelets and an inner fibrin mesh reinforced by additional platelets.

This phase is rapid. A small wound generates a visible clot within 5 to 10 minutes. The clot remains in place, sealing the wound and preventing further blood loss, while also serving as a structural scaffold for the next phase of healing.

Source: Furie, B. and Furie, B.C. (2008), "Mechanisms of thrombus formation," New England Journal of Medicine, Vol. 359 — comprehensive review of hemostasis and coagulation cascades.

Inflammation: Clearing Debris and Recruiting Repair Cells

Hours after the clot forms, inflammation begins. The inflammatory response is essential for wound healing, not harmful, despite inflammation's reputation as a destructive force. Without inflammation, wounds do not heal. Inflammation's role is threefold: clear bacteria and dead cells, release growth factors that stimulate tissue repair, and recruit immune and repair cells to the wound site.

Neutrophils — the most abundant white blood cells in circulation — are the first immune cells to arrive, migrating into the wound within the first 12 to 24 hours. They are attracted by chemokines, small signaling proteins released by platelets, endothelial cells, and resident cells at the wound site. Neutrophils kill bacteria, engulf dead cells and debris, and release enzymes and reactive oxygen species that break down damaged tissue. They are, in a sense, the cleanup crew, clearing the "debris field" so that tissue repair can proceed.

Within 24 to 48 hours, macrophages — larger immune cells derived from circulating monocytes — arrive and take over the primary phagocytic role from neutrophils. Macrophages are more important for wound healing than neutrophils because they release growth factors, particularly transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and fibroblast growth factor (FGF). These growth factors are the chemical signals that tell fibroblasts and endothelial cells to proliferate and begin rebuilding tissue.

Edema — swelling caused by fluid accumulation in the wound — is a hallmark of acute inflammation. When blood vessels are damaged, they become leaky, allowing fluid and cells to seep into surrounding tissue. This fluid dilutes wound contaminants, brings in immune molecules and growth factors, and makes room for immune and repair cells to accumulate. Edema subsides as the wound transitions to the proliferative phase.

The inflammatory phase typically lasts 4 to 6 days in uncomplicated wounds. It overlaps substantially with the proliferative phase; the two phases are not strictly sequential.

Source: Eming, S.A., Krieg, T., and Davidson, J.M. (2007), "Inflammation in wound repair: molecular and cellular mechanisms," Journal of Dental Research, Vol. 86 — detailed analysis of immune cell recruitment and growth factor signaling in wound inflammation.

Proliferation: Building New Tissue

The proliferative phase is dominated by two processes: angiogenesis (formation of new blood vessels) and fibroplasia (collagen deposition by fibroblasts). This phase begins as early as day 3 to 5 and can last 2 to 3 weeks.

Fibroblasts — connective tissue cells — are the primary architects of the new tissue. They are recruited to the wound from surrounding tissue and circulating precursor cells, drawn by growth factors (TGF-β, FGF, PDGF) released by macrophages and platelets. Once in the wound, fibroblasts proliferate rapidly and begin synthesizing collagen, the primary structural protein of skin and connective tissue.

Collagen is not a single molecule but a family of proteins. Type I collagen is the most abundant in skin and is the primary collagen deposited during wound healing. Fibroblasts synthesize collagen molecules (tropocollagen) in the rough endoplasmic reticulum, modify them (hydroxylation of proline and lysine residues, essential for cross-linking), and secrete them into the extracellular matrix. In the wound, collagen molecules self-assemble into triple-helical fibrils and fibers that provide tensile strength.

During the proliferative phase, collagen accumulates rapidly. A deep wound may accumulate 5 to 10 grams of collagen per square centimeter. Initially, this collagen is deposited in a disorganized manner, and the wound tissue is weak. Over days and weeks, collagen fibers are cross-linked by the enzyme lysyl oxidase (which oxidizes lysine residues to reactive aldehydes that form covalent bonds between collagen molecules), stabilizing and strengthening the tissue.

Angiogenesis — the formation of new blood vessels — is critical because new tissue requires oxygen and nutrients. Endothelial cells (cells lining blood vessels) are stimulated by VEGF and FGF to proliferate and migrate into the wound. These cells organize into new capillary tubes, reconnecting the wound tissue to the body's circulatory system. New blood vessels are initially leaky and fragile; they mature and stabilize over time as pericytes (supportive cells surrounding capillaries) wrap around them.

Granulation tissue is the temporary tissue formed during the proliferative phase. It consists of a meshwork of collagen fibers, new blood vessels, fibroblasts, and immune cells. It is reddish or pinkish in color due to the abundance of blood vessels. Granulation tissue is a scaffold that supports further tissue repair and will eventually be replaced by more organized, mature tissue during remodeling.

Proliferative Feature	Timeline	Function	Key Cells
Fibroblast recruitment	Days 3–5	Cell proliferation and collagen synthesis	Fibroblasts, myofibroblasts
Collagen deposition	Days 5–21	Build structural scaffold and tensile strength	Fibroblasts
Angiogenesis (new blood vessels)	Days 5–21	Restore oxygen and nutrient supply to wound tissue	Endothelial cells, pericytes
Granulation tissue formation	Days 5–21	Provide temporary scaffold for epithelial cells to resurface wound	Mixed cell types
Epithelialization	Days 1–30	Rebuild outer skin layer (epidermis)	Keratinocytes from wound edges

Source: Singer, A.J. and Clark, R.A.F. (1999), "Cutaneous wound healing," New England Journal of Medicine, Vol. 341 — landmark review of the proliferative phase and the roles of growth factors, collagen, and angiogenesis.

Remodeling and Scar Maturation: Why Scars Form

The remodeling phase begins around week 3 and can continue for a year or more. During remodeling, the granulation tissue is reorganized, and scar tissue forms.

Scar formation occurs because the body cannot perfectly replicate the original tissue architecture. During wound healing, collagen is deposited in excess and without the precise organization of unwounded skin. The normal dermis (the layer of skin beneath the epidermis) has collagen arranged in a specific pattern with hair follicles, sweat glands, and other structures interspersed throughout. When a wound heals, the new collagen is deposited as a dense, disorganized mass without these structures. The result is scar tissue, which is mechanically stronger (more cross-linked collagen) but functionally inferior (no hair follicles, sweat glands, or sensation).

Myofibroblasts — cells with properties intermediate between fibroblasts and smooth muscle cells — play a crucial role in scar formation. These cells appear in the wound during the proliferative phase and persist into early remodeling. Myofibroblasts express α-smooth muscle actin (α-SMA) and are capable of contracting, generating tension that pulls the wound edges together. This process, called wound contraction, reduces wound size. In small, superficial wounds, wound contraction is minor. In large or deep wounds, myofibroblast contraction can substantially reduce the wound size, which is beneficial for closure but can also cause contractures — permanent, rigid deformities if excessive contraction occurs around joints or on the face.

During remodeling, fibroblasts gradually reduce collagen synthesis, and the rate of collagen degradation increases. Matrix metalloproteinases (MMPs) — enzymes that break down collagen and other extracellular matrix proteins — are upregulated. The balance between collagen deposition and degradation shifts, and the amount of collagen in the scar tissue begins to stabilize. Additionally, many of the cells in the granulation tissue (including fibroblasts and myofibroblasts) undergo programmed cell death (apoptosis), reducing the cellularity of the scar.

The scar tissue gradually becomes less vascular (fewer blood vessels), paler, and more fibrous over months. The tensile strength of the scar continues to increase as collagen cross-linking proceeds, but it will never match the strength of the original skin, reaching approximately 80 to 90 percent of the original strength even after a year.

Hypertrophic scars — thickened, raised scars — form when collagen deposition exceeds the rate of remodeling and collagen degradation. This occurs more commonly in areas of high tension (such as the chest, shoulders, and joints), in younger individuals (who have faster collagen synthesis rates), in individuals with darker skin tones (who have a higher prevalence of hypertrophic scars), and following burns or deep wounds. Keloid scars — excessive scars that extend beyond the original wound boundaries — are even more pronounced and appear to result from an exaggerated fibroblast response to injury.

Understanding this process is critical: wound healing is a perfectly normal response to injury, but the outcome depends on the wound's depth, location, patient age, nutritional status, and whether infection or other complications occur.

Source: Gurtner, G.C., Werner, S., Barrandon, Y., and Longaker, M.T. (2008), "Wound repair and regeneration," Nature, Vol. 453 — comprehensive review of remodeling, scar formation, and the role of myofibroblasts.

Source: Bayat, A., McGrouther, D.A., and Ferguson, M.W.J. (2003), "Pathophysiology of abnormal scar formation: role of growth factors and cytokines," British Journal of Surgery, Vol. 90 — detailed analysis of hypertrophic and keloid scar formation.

Factors That Accelerate or Impede Wound Healing

Wound healing is not a one-size-fits-all process. Several biological and environmental factors significantly alter healing rate and quality.

Age is one of the most significant factors. Older adults heal more slowly than younger individuals. This delay occurs at multiple stages: hemostasis is intact, but the inflammatory phase is prolonged, immune cells are recruited more slowly, fibroblasts proliferate less vigorously, angiogenesis is diminished, and collagen synthesis decreases. Additionally, elderly skin has thinner dermis (fewer fibroblasts), reduced blood flow, and reduced capacity for growth factor signaling. A wound that might heal in 2 weeks in a 25-year-old might take 4 to 6 weeks in an 85-year-old.

Nutrition directly impacts collagen synthesis. Proteins are the building blocks of collagen, and certain micronutrients are essential cofactors. Vitamin C is a cofactor for the enzymes that hydroxylate proline and lysine residues in collagen, a step essential for collagen cross-linking and stability. Vitamin C deficiency results in unstable collagen and impaired healing. Zinc is a cofactor for the enzyme lysyl oxidase, which cross-links collagen. Zinc deficiency delays the proliferative phase and reduces collagen cross-linking. Iron is required for hemoglobin synthesis and oxygen transport; iron deficiency impairs angiogenesis. A patient with malnutrition (particularly protein, vitamin C, and zinc deficiency) will heal slowly and produce weak scar tissue.

Blood glucose (diabetes) is a major risk factor for impaired healing. In uncontrolled diabetes (elevated blood glucose), several mechanisms go awry. High glucose impairs immune cell function, reducing the ability of neutrophils and macrophages to kill bacteria and clear debris. High glucose also impairs angiogenesis, reducing new blood vessel formation. Additionally, high glucose leads to glycation — non-enzymatic modification of proteins by glucose — which cross-links collagen abnormally and reduces its mechanical properties. Diabetic patients have a 10-fold higher risk of chronic (non-healing) wounds compared to non-diabetic individuals, particularly on the feet.

Infection is perhaps the most significant impediment to healing. Bacterial growth in the wound triggers excessive inflammation, consuming growth factors and producing toxins that kill fibroblasts and endothelial cells. A bacterial load exceeding 10^5 organisms per gram of tissue (approximately 100,000 bacteria per milliliter) is typically considered a critical threshold for clinical infection. Biofilms — organized, antibiotic-resistant communities of bacteria encased in polysaccharide matrices — further complicate healing by preventing immune cells and antibiotics from reaching bacteria.

Oxygen supply is critical. Fibroblasts require oxygen to synthesize collagen, and the hydroxylation of proline and lysine residues is an oxygen-dependent process. Wounds in areas with poor blood flow (such as the foot or lower leg) heal slowly. Additionally, hypoxia — low oxygen — triggers angiogenesis through HIF-1α (hypoxia-inducible factor-1 alpha), a transcription factor that upregulates VEGF and other pro-angiogenic genes. Paradoxically, some hypoxia is beneficial for triggering angiogenesis, but severe hypoxia is detrimental.

Chronic wounds — wounds that do not heal within 4 weeks — are common in elderly, diabetic, and immobilized patients. In chronic wounds, the inflammatory phase fails to resolve, immune cells persist, growth factor signaling is dysregulated, and the balance between collagen deposition and degradation is lost. Some chronic wounds may persist for years.

Source: Guo, S. and DiPietro, L.A. (2010), "Factors affecting wound healing," Journal of Dental Research, Vol. 89 — comprehensive review of age, nutrition, infection, and other factors affecting healing.

The Role of Growth Factors and Signaling Molecules

Wound healing is orchestrated by a complex array of signaling molecules, particularly growth factors and cytokines. These are secreted proteins that bind to receptors on target cells and trigger cascades of molecular events.

TGF-β (Transforming Growth Factor-Beta) is perhaps the most important growth factor in wound healing. It is released by platelets during clotting and by macrophages during inflammation. TGF-β stimulates fibroblasts to proliferate and synthesize collagen. It also recruits immune cells and promotes angiogenesis. Additionally, TGF-β promotes the differentiation of fibroblasts into myofibroblasts, which contributes to wound contraction. TGF-β is present throughout wound healing and even drives excessive collagen deposition in hypertrophic and keloid scars.

VEGF (Vascular Endothelial Growth Factor) specifically promotes angiogenesis. It is produced by macrophages, fibroblasts, and hypoxic cells in the wound. VEGF binds to receptors on endothelial cells, stimulating their proliferation and migration into the wound to form new blood vessels. Without VEGF, wounds remain ischemic and fail to heal.

FGF (Fibroblast Growth Factor) also promotes fibroblast proliferation and angiogenesis. Additionally, PDGF (Platelet-Derived Growth Factor) — released by platelets — recruits fibroblasts and macrophages to the wound.

IL-6 (Interleukin-6) and TNF-α (Tumor Necrosis Factor-Alpha) are pro-inflammatory cytokines released by immune cells. They amplify the inflammatory response and recruit additional immune cells. In acute wounds, these cytokines are beneficial, but chronic elevation of TNF-α and IL-6 is associated with chronic wound failure.

These growth factors and cytokines form a tightly regulated signaling network. The balance between pro-inflammatory and pro-healing signals determines whether a wound heals normally or becomes chronic. In chronic wounds, this balance is disrupted: pro-inflammatory signals persist, growth factor signaling is diminished, and healing stalls.

Source: Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H., and Tomic-Canic, M. (2008), "Growth factors and cytokines in wound healing," Wound Repair and Regeneration, Vol. 16 — detailed review of growth factor signaling in all four phases of wound healing.

Connecting Wound Healing to Broader Physiology

Wound healing is intimately connected to other systems. How the immune system works is central because macrophages and neutrophils drive the inflammatory phase and recruit fibroblasts. Understanding how blood works is essential because platelets initiate clotting and hemostasis. How the skin works, the body's largest organ, determines the baseline architecture that wound healing must restore. Additionally, why we age explains the slowed healing in elderly patients, and how muscles grow involves similar growth factor signaling (TGF-β, IGF-1) and collagen remodeling that occurs in wounds. The skin also hosts hair follicles; see how hair grows.

What People Get Wrong: Common Misconceptions About Wound Healing

Misconception 1: Wounds should be kept dry. This is false. Moist wound environment accelerates healing. Wounds kept moist have higher re-epithelialization rates and produce less scar tissue compared to wounds left to air dry. Modern wound dressings (hydrocolloids, foams, silicones) maintain moisture while preventing bacterial contamination. The old practice of allowing wounds to "air out" is outdated.

Misconception 2: Inflammation is bad and should be suppressed. This is partially false. The inflammatory phase is essential for clearing bacteria, removing dead cells, and releasing growth factors. Excessive inflammation (in chronic wounds or severe burns) can be detrimental, but suppressing inflammation in an acute wound delays healing and increases infection risk. A degree of inflammation is necessary and normal.

Misconception 3: Once a scar forms, it cannot be improved. This is false. Scars continue to remodel for 12 to 24 months after injury. Some scars fade naturally as collagen remodels. Others can be improved with interventions: pressure garments, silicone gels, topical agents (onion extract, vitamin E), laser therapy, subcision, or surgical revision. The scar is not permanent and unchanging.

Misconception 4: Vitamin E accelerates healing. This is not clearly supported. While vitamin E is an antioxidant, studies on topical vitamin E for wound healing show mixed results. Some studies suggest it may help, others show no benefit or even slight impairment of healing. The evidence is weak, and routine vitamin E supplementation for wound healing is not recommended by evidence-based guidelines.

Misconception 5: Larger wounds take proportionally longer to heal. This is not strictly true. Healing rate (area healed per day) often increases with wound size because more macrophages and fibroblasts are recruited. A 1 cm wound might heal in 1 week, but a 10 cm wound might heal in 3 to 4 weeks (not 10 weeks). However, this relationship breaks down for very large wounds or wounds with significant tissue loss.

The Takeaway

Wound healing is a four-phase process orchestrated by platelets, immune cells, fibroblasts, and growth factors. Each phase is distinct yet overlapping, and disruption at any stage results in delayed or abnormal healing. Scars form not from failure, but from the body's imperfect ability to replicate the original tissue structure; scar tissue is less functional but often stronger. Age, nutrition, infection, blood glucose, and blood supply are the primary modifiable factors that impact healing. Understanding these mechanisms is not merely academic; it directly informs clinical practice, allowing physicians to optimize conditions for healing (controlling blood glucose in diabetics, ensuring adequate nutrition, managing infection, maintaining moist wound environment) and to predict and manage complications like chronic wounds and hypertrophic scars.

Frequently Asked Questions

Q: Why do wounds itch as they heal?
A: Itching during wound healing is thought to be caused by several factors: nerve regeneration (sensory nerves regrowing into the healing tissue), histamine release from immune cells and mast cells, cytokine signaling that activates itch receptors, and collagen remodeling. Itching often peaks during the proliferative and early remodeling phases when new tissue is forming most actively. Scratching the wound risks reopening it or introducing infection, so keeping the area clean and using gentle topical agents or antihistamines can help manage the itch.

Q: Can you speed up wound healing, or is it fixed by genetics and age?
A: Both genetics and age influence healing rate, but healing can be optimized. Ensuring adequate nutrition (protein, vitamin C, zinc), maintaining good blood glucose control (if diabetic), staying hydrated, avoiding smoking (which impairs angiogenesis), managing stress, and using optimal wound care (moist dressings, infection prevention) can all accelerate healing. Growth factor therapies and advanced dressings exist for chronic wounds. However, you cannot dramatically accelerate an inherently slow process in an elderly patient; rather, you can optimize conditions to achieve the best possible outcome for that individual.

Q: Why do different parts of the body heal at different rates?
A: Healing rate depends on blood supply, skin thickness, tension on the wound, and the presence of underlying structures. Face and scalp wounds heal quickly (abundant blood supply, thin skin, high tension stimulates fibroblast activity). Wounds on the lower leg or foot heal slowly (poor blood supply, thick skin, low tension). Wounds over joints heal slowly because movement disrupts newly forming tissue. Deeper wounds take longer than superficial wounds because more tissue volume must be replaced.

Q: What is the difference between a scar and a keloid?
A: A scar is the normal outcome of wound healing—dense, less functional tissue that replaces the original wound. A scar typically matures and fades over 12 to 24 months. A keloid is an abnormal, exuberant scar that extends beyond the original wound boundaries and continues to grow even after healing is complete. Keloids are more common in individuals with darker skin tones and in certain body locations (chest, shoulders, ears). Unlike scars, keloids rarely regress spontaneously and often require medical intervention (injection, surgery, laser therapy).

Q: Can chronic wounds ever heal, or are they permanent?
A: Chronic wounds can heal, but they require intervention. Simple chronic wound management—keeping the wound clean and moist, managing infection, optimizing nutrition and blood glucose, offloading pressure (in pressure ulcers), and improving blood flow—leads to healing in many cases. Advanced therapies like growth factor therapies, skin grafts, or negative pressure wound therapy (vacuum-assisted closure) are used for stubborn chronic wounds. However, some chronic wounds (particularly in end-stage vascular disease or severe diabetes) may not be healable and may require amputation or palliative care.

Q: Do antibiotics speed up wound healing?
A: Antibiotics do not directly speed healing; rather, they prevent infection, which allows normal healing to proceed. A sterile wound heals much faster than an infected one. Prophylactic antibiotics (given to prevent infection) are standard after surgery. However, antibiotic ointments on clean, minor wounds offer minimal benefit and are not recommended by current guidelines. Antibiotics are essential when infection is present or at high risk, but they are not a healing accelerant.

---

Read next:

• How the Immune System Works
• How the Skin Works: Your Largest Organ
• How Blood Works Explained